Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1Endometrial Neoplasms 1

Interventions

adavosertib 2Trastuzumab 2Fulvestrant 2ulixertinib 1tucatinib 1trastuzumab biosimilar HLX02 1trametinib 1sapanisertib 1relatlimab 1pertuzumab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1defactinib 1dabrafenib 1copanlisib 1cemiplimab 1capivasertib 1binimetinib 1X-Rays 1Sunitinib 1Specimen Handling 1Radionuclide Imaging 1Radiomics 1Paclitaxel 1PF-05280014 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Uterine Neoplasms × Radiomics × Clear all
NCT06963385 2025-05-09

ROME

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
250 enrolled
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡